NeuroOne Medical Technologies Corp (NMTC)
0.711
-0.07
(-8.96%)
USD |
NASDAQ |
Nov 15, 16:00
0.7189
+0.01
(+1.11%)
After-Hours: 20:00
NeuroOne Medical Technologies Research and Development Expense (TTM): 5.731M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 5.731M |
March 31, 2024 | 6.428M |
December 31, 2023 | 6.860M |
September 30, 2023 | 6.941M |
June 30, 2023 | 6.600M |
March 31, 2023 | 5.933M |
December 31, 2022 | 5.432M |
September 30, 2022 | 4.929M |
June 30, 2022 | 4.500M |
March 31, 2022 | 4.175M |
December 31, 2021 | 4.051M |
September 30, 2021 | 3.925M |
June 30, 2021 | 3.701M |
Date | Value |
---|---|
March 31, 2021 | 3.248M |
December 31, 2020 | 2.508M |
September 30, 2020 | 2.076M |
June 30, 2020 | 1.752M |
March 31, 2020 | 1.728M |
December 31, 2019 | 1.822M |
September 30, 2019 | 1.529M |
June 30, 2019 | 1.294M |
March 31, 2019 | 0.9761M |
December 31, 2018 | 0.7747M |
June 30, 2018 | 0.8372M |
March 31, 2018 | 0.7683M |
December 31, 2017 | 0.7353M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.728M
Minimum
Mar 2020
6.941M
Maximum
Sep 2023
4.334M
Average
4.175M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
SINTX Technologies Inc | 8.045M |
Nutriband Inc | 2.863M |
enVVeno Medical Corp | 11.72M |
Beyond Air Inc | 25.68M |
CVRx Inc | 10.57M |